268 related articles for article (PubMed ID: 24878374)
1. Margatoxin is a non-selective inhibitor of human Kv1.3 K+ channels.
Bartok A; Toth A; Somodi S; Szanto TG; Hajdu P; Panyi G; Varga Z
Toxicon; 2014 Sep; 87():6-16. PubMed ID: 24878374
[TBL] [Abstract][Full Text] [Related]
2. Tst26, a novel peptide blocker of Kv1.2 and Kv1.3 channels from the venom of Tityus stigmurus.
Papp F; Batista CV; Varga Z; Herceg M; Román-González SA; Gaspar R; Possani LD; Panyi G
Toxicon; 2009 Sep; 54(4):379-89. PubMed ID: 19500613
[TBL] [Abstract][Full Text] [Related]
3. sVmKTx, a transcriptome analysis-based synthetic peptide analogue of Vm24, inhibits Kv1.3 channels of human T cells with improved selectivity.
Csoti A; Del Carmen Nájera Meza R; Bogár F; Tajti G; Szanto TG; Varga Z; Gurrola GB; Tóth GK; Possani LD; Panyi G
Biochem Pharmacol; 2022 May; 199():115023. PubMed ID: 35358481
[TBL] [Abstract][Full Text] [Related]
4. Anuroctoxin, a new scorpion toxin of the alpha-KTx 6 subfamily, is highly selective for Kv1.3 over IKCa1 ion channels of human T lymphocytes.
Bagdány M; Batista CV; Valdez-Cruz NA; Somodi S; Rodriguez de la Vega RC; Licea AF; Varga Z; Gáspár R; Possani LD; Panyi G
Mol Pharmacol; 2005 Apr; 67(4):1034-44. PubMed ID: 15615696
[TBL] [Abstract][Full Text] [Related]
5. Margatoxin-bound quantum dots as a novel inhibitor of the voltage-gated ion channel Kv1.3.
Schwartz AB; Kapur A; Wang W; Huang Z; Fardone E; Palui G; Mattoussi H; Fadool DA
J Neurochem; 2017 Feb; 140(3):404-420. PubMed ID: 27861889
[TBL] [Abstract][Full Text] [Related]
6. A new Kaliotoxin selective towards Kv1.3 and Kv1.2 but not Kv1.1 channels expressed in oocytes.
Abbas N; Belghazi M; Abdel-Mottaleb Y; Tytgat J; Bougis PE; Martin-Eauclaire MF
Biochem Biophys Res Commun; 2008 Nov; 376(3):525-30. PubMed ID: 18804453
[TBL] [Abstract][Full Text] [Related]
7. A selective blocker of Kv1.2 and Kv1.3 potassium channels from the venom of the scorpion Centruroides suffusus suffusus.
Corzo G; Papp F; Varga Z; Barraza O; Espino-Solis PG; Rodríguez de la Vega RC; Gaspar R; Panyi G; Possani LD
Biochem Pharmacol; 2008 Oct; 76(9):1142-54. PubMed ID: 18786511
[TBL] [Abstract][Full Text] [Related]
8. Peptidyl inhibitors of shaker-type Kv1 channels elicit twitches in guinea pig ileum by blocking kv1.1 at enteric nervous system and enhancing acetylcholine release.
Suarez-Kurtz G; Vianna-Jorge R; Pereira BF; Garcia ML; Kaczorowski GJ
J Pharmacol Exp Ther; 1999 Jun; 289(3):1517-22. PubMed ID: 10336547
[TBL] [Abstract][Full Text] [Related]
9. A potent potassium channel blocker from Mesobuthus eupeus scorpion venom.
Gao B; Peigneur S; Tytgat J; Zhu S
Biochimie; 2010 Dec; 92(12):1847-53. PubMed ID: 20713119
[TBL] [Abstract][Full Text] [Related]
10. The antibody targeting the E314 peptide of human Kv1.3 pore region serves as a novel, potent and specific channel blocker.
Yang XF; Yang Y; Lian YT; Wang ZH; Li XW; Cheng LX; Liu JP; Wang YF; Gao X; Liao YH; Wang M; Zeng QT; Liu K
PLoS One; 2012; 7(4):e36379. PubMed ID: 22558454
[TBL] [Abstract][Full Text] [Related]
11. Margatoxin binds to a homomultimer of K(V)1.3 channels in Jurkat cells. Comparison with K(V)1.3 expressed in CHO cells.
Helms LM; Felix JP; Bugianesi RM; Garcia ML; Stevens S; Leonard RJ; Knaus HG; Koch R; Wanner SG; Kaczorowski GJ; Slaughter RS
Biochemistry; 1997 Mar; 36(12):3737-44. PubMed ID: 9132027
[TBL] [Abstract][Full Text] [Related]
12. 5-Chloro-2-Guanidinobenzimidazole (ClGBI) Is a Non-Selective Inhibitor of the Human H
Szanto TG; Feher A; Korpos E; Gyöngyösi A; Kállai J; Mészáros B; Ovari K; Lányi Á; Panyi G; Varga Z
Pharmaceuticals (Basel); 2023 Apr; 16(5):. PubMed ID: 37242439
[TBL] [Abstract][Full Text] [Related]
13. An engineered scorpion toxin analogue with improved Kv1.3 selectivity displays reduced conformational flexibility.
Bartok A; Fehér K; Bodor A; Rákosi K; Tóth GK; Kövér KE; Panyi G; Varga Z
Sci Rep; 2015 Dec; 5():18397. PubMed ID: 26689143
[TBL] [Abstract][Full Text] [Related]
14. N-Terminally extended analogues of the K⁺ channel toxin from Stichodactyla helianthus as potent and selective blockers of the voltage-gated potassium channel Kv1.3.
Chang SC; Huq R; Chhabra S; Beeton C; Pennington MW; Smith BJ; Norton RS
FEBS J; 2015 Jun; 282(12):2247-59. PubMed ID: 25864722
[TBL] [Abstract][Full Text] [Related]
15. Structure, molecular modeling, and function of the novel potassium channel blocker urotoxin isolated from the venom of the Australian scorpion Urodacus yaschenkoi.
Luna-Ramírez K; Bartok A; Restano-Cassulini R; Quintero-Hernández V; Coronas FI; Christensen J; Wright CE; Panyi G; Possani LD
Mol Pharmacol; 2014 Jul; 86(1):28-41. PubMed ID: 24723491
[TBL] [Abstract][Full Text] [Related]
16. Solid phase synthesis, NMR structure determination of α-KTx3.8, its in silico docking to Kv1.x potassium channels, and electrophysiological analysis provide insights into toxin-channel selectivity.
Kohl B; Rothenberg I; Ali SA; Alam M; Seebohm G; Kalbacher H; Voelter W; Stoll R
Toxicon; 2015 Jul; 101():70-8. PubMed ID: 25953725
[TBL] [Abstract][Full Text] [Related]
17. Identification and biochemical characterization of a novel nortriterpene inhibitor of the human lymphocyte voltage-gated potassium channel, Kv1.3.
Felix JP; Bugianesi RM; Schmalhofer WA; Borris R; Goetz MA; Hensens OD; Bao JM; Kayser F; Parsons WH; Rupprecht K; Garcia ML; Kaczorowski GJ; Slaughter RS
Biochemistry; 1999 Apr; 38(16):4922-30. PubMed ID: 10213593
[TBL] [Abstract][Full Text] [Related]
18. Characterization and Chemical Synthesis of Cm39 (α-KTx 4.8): A Scorpion Toxin That Inhibits Voltage-Gated K
Naseem MU; Gurrola-Briones G; Romero-Imbachi MR; Borrego J; Carcamo-Noriega E; Beltrán-Vidal J; Zamudio FZ; Shakeel K; Possani LD; Panyi G
Toxins (Basel); 2023 Jan; 15(1):. PubMed ID: 36668861
[TBL] [Abstract][Full Text] [Related]
19. Mapping of maurotoxin binding sites on hKv1.2, hKv1.3, and hIKCa1 channels.
Visan V; Fajloun Z; Sabatier JM; Grissmer S
Mol Pharmacol; 2004 Nov; 66(5):1103-12. PubMed ID: 15286210
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the σ-Pore in Mutant hKv1.3 Potassium Channels.
Tyutyaev P; Grissmer S
Cell Physiol Biochem; 2018; 46(3):1112-1121. PubMed ID: 29669325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
